SCHEMBL26528233

SCHEMBL26528233

COCC1CCn2nc(-c3ccc(CNC(=O)OC(C)(C)C)cc3)nc2C1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 3/20 0.41
▸ HDAC1 Q13547 3/20 0.41
▸ GPR119 Q8TDV5 1/20 0.39
▸ CKS1B P61024 1/20 0.39
▸ SKP1 P63208 1/20 0.39
▸ SKP2 Q13309 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ROCK2 O75116 1/20 0.38
▸ HPN P05981 1/20 0.38
▸ ACACB O00763 4/20 0.37
▸ ACACA Q13085 4/20 0.37
▸ BRD4 O60885 1/20 0.37
▸ PDE10A Q9Y233 1/20 0.36
▸ GRM2 Q14416 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26527383 0.88 NAMPT (0.44) NAMPTHDAC1GPR119CKS1BSKP1
SCHEMBL26528084 0.88 NAMPT (0.41) NAMPTHDAC1GPR119CKS1BSKP1
SCHEMBL26527249 0.87 NAMPT (0.42) NAMPTHDAC1GPR119L3MBTL1ROCK2
SCHEMBL26527978 0.86 NAMPT (0.44) NAMPTHDAC1GPR119L3MBTL1ROCK2
SCHEMBL26526564 0.86 NAMPT (0.44) NAMPTHDAC1GPR119L3MBTL1ROCK2
SCHEMBL26528714 0.86 NAMPT (0.44) NAMPTHDAC1GPR119L3MBTL1ROCK2
SCHEMBL26527335 0.85 NAMPT (0.45) NAMPTHDAC1GPR119L3MBTL1ROCK2
SCHEMBL26527432 0.85 NAMPT (0.40) NAMPTHDAC1GPR119L3MBTL1ROCK2
SCHEMBL26527518 0.84 NAMPT (0.45) NAMPTHDAC1GPR119L3MBTL1ROCK2
SCHEMBL26526412 0.84 NAMPT (0.42) NAMPTHDAC1GPR119L3MBTL1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023073090-A1 IMIDAZOPYRIDINE AMIDES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS Janssen Sciences Ireland Unlimited Company (IE) 2023-05-04 — — WO disclosed
Send feedback